Trial Profile
A 12-Week Randomized, Double-Blinded Study to Evaluate the Effects of Daily Oral Doses of BMS-741672 in Drug-Naive Type 2 Diabetic Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs BMS 741672 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 29 Jun 2010 Actual patient number (58) added as reported by ClinicalTrials.gov.
- 29 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.